Paper305674
Thymosin treatment of children with primary immunodeficiency disease.
Wara DW and 1 other. Transplant Proc, 1978. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Thymosin treatment of children with primary immunodeficiency disease. Papers, record 305674. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/305674
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunologic Deficiency Syndromes | Major topic |
| Thymosin | Major topic |
| Thymus Hormones | Major topic |
| Adolescent | |
| Agammaglobulinemia | |
| Ataxia Telangiectasia | |
| Burkitt Lymphoma | |
| Candidiasis, Cutaneous | |
| Child | |
| Child, Preschool | |
| Chronic Disease | |
| Female | |
| Humans | |
| Lymphatic Diseases | |
| Male | |
| Middle Aged | |
| Syndrome | |
| T-Lymphocytes | |
| Thymus Gland |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7094423 | Dual action of leucocyte dialysates and of thymosin on the recovery of sheep-cell-rosetting capacity in trypsinized human lymphocytes. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/7094423 | PubMed |
| 7032772 | Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7032772 | PubMed |
| 6478652 | Experimental autoimmune thyroiditis: modulation of the disease level in high and low responder mice by thymosin. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6478652 | PubMed |
| 6334692 | Influenza and aging: age-related changes and the effects of thymosin on the antibody response to influenza vaccine. | J Clin Immunol | 1984 | https://conductscience.org/library/papers/6334692 | PubMed |
| 6239686 | Immunomodulation and therapeutic characterization of thymosin fraction five. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6239686 | PubMed |
| 3971596 | Intestinal lymphangiectasia and thymic hypoplasia. | Clin Exp Immunol | 1985 | https://conductscience.org/library/papers/3971596 | PubMed |
| 2502409 | Chronic mucocutaneous candidiasis. | Eur J Clin Microbiol Infect Dis | 1989 | https://conductscience.org/library/papers/2502409 | PubMed |
| 42651 | Combined immunodeficiency and thymic abnormalities. | J Clin Pathol Suppl (R Coll Pathol) | 1979 | https://conductscience.org/library/papers/42651 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/305674
GET https://conductscience.org/api/papers/v1/305674/authors